Open AccessManagement Strategies for Microalbuminuria in Diabetes Mellitus – an Overview
Author(s) -
Kaushal Kishore,
Anup Sharma
Publication year - 2003
Publication title -
journal of nepal medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.176
H-Index - 19
eISSN - 1815-672X
pISSN - 0028-2715
DOI - 10.31729/jnma.642
Subject(s) - microalbuminuria , medicine , diabetes mellitus , type 2 diabetes mellitus , creatinine , albuminuria , kidney disease , disease , endocrinology , urology
Microalbuminuria (MA) in individuals with diabetes mellitus (DM) is associated with markedly reducedsurvival, increased risk of cardiovascular disease and is predictive of later development of an overt DiabeticKidney Disease (DKD) and progressive renal failure. Patients with type 1 DM from 5 years after diagnosisand type 2 DM from the time of diagnosis should be screened annually for MA by sensitive stick test in spotcollection or Albumin Excretion Rate (AER) in the timed collection of urine. AER. of 20-200µg/min (30-300mg/24hr) or Albumin : Creatinine ratio (ACR) >2.5 is labelled as MA. ACE Inhibitor / Angiotensin IIReceptor Blocker (ARB) therapy along with improved glycaemic control is the key to prevent or slow theprogression of DKD.Key Words: Microalbuminuria, Diabetes Mellitus, Diabetic Kidney Disease.